These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3287734)

  • 41. Comparison of oxyphenbutazone and placebo in the treatment of superficial thrombophelbitis: an object lesson in clinical trial design.
    Archer DS; Fowler PD
    Practitioner; 1977 May; 218(1307):712-5. PubMed ID: 329257
    [No Abstract]   [Full Text] [Related]  

  • 42. Dextran or warfarin: which drug to follow heparin?
    Nolan TR; Crumbley AJ; Grady ED; Rosen AJ
    J Med Assoc Ga; 1979 Nov; 68(11):969-70. PubMed ID: 501235
    [No Abstract]   [Full Text] [Related]  

  • 43. The value of protamine following heparin-covered angiography: double-blind placebo-controlled study.
    Dotter CT; Keller FS; Rösch J; Buschman RW
    Radiology; 1980 Apr; 135(1):229-30. PubMed ID: 6987705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of recurrent venous thrombosis: warfarin versus heparin.
    Barker AF
    N Engl J Med; 1980 Mar; 302(13):753. PubMed ID: 7354793
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of sodium and calcium heparin in prevention of venous thromboembolism.
    Cade JF; Andrews JT; Stubbs AE
    Aust N Z J Med; 1982 Oct; 12(5):501-4. PubMed ID: 6758747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticoagulant therapy with warfarin.
    Paul B
    Cent Afr J Med; 1990 Aug; 36(8):199. PubMed ID: 2282651
    [No Abstract]   [Full Text] [Related]  

  • 47. Successful treatment of ileofemoral venous thrombosis following cardiac catheterization.
    Whittaker M; Kerr RV
    Thorax; 1973 Nov; 28(6):794-6. PubMed ID: 4787993
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of heparin and warfarin on antithrombin III.
    O'Brien JR; Etherington MD
    Lancet; 1977 Dec; 2(8050):1231. PubMed ID: 73931
    [No Abstract]   [Full Text] [Related]  

  • 49. Deep venous thrombosis, inflammatory bowel disease, and protein S deficiency.
    Wyshock E; Caldwell M; Crowley JP
    Am J Clin Pathol; 1988 Nov; 90(5):633-5. PubMed ID: 2972196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemostatic abnormalities and malignant disease.
    Lancet; 1986 Mar; 1(8482):677. PubMed ID: 2869363
    [No Abstract]   [Full Text] [Related]  

  • 51. Classical anticoagulant therapy for venous thromboembolism.
    Pineo GF; Hull RD
    Prog Cardiovasc Dis; 1994; 37(2):59-70. PubMed ID: 8078976
    [No Abstract]   [Full Text] [Related]  

  • 52. Warfarin and hydroxyethylrutosides in deep vein thrombosis.
    Eastham RD; Perham TG; Pocock PV
    Br Med J; 1972 Nov; 4(5838):491. PubMed ID: 4653895
    [No Abstract]   [Full Text] [Related]  

  • 53. [Round table on the treatment of deep venous thrombosis. The experiences in our phlebology department].
    Marzin L
    Phlebologie; 1990; 43(4):643-4. PubMed ID: 2093919
    [No Abstract]   [Full Text] [Related]  

  • 54. Anticoagulant treatment in sarcoidosis.
    Hedfors E
    Acta Med Scand; 1977; 202(3):237-40. PubMed ID: 910643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concurrent initiation of heparin and warfarin therapy.
    Self TH; Bauman JH; Brown JR; Bickers WJ; Wood CA
    Am Heart J; 1981 Sep; 102(3 Pt 1):470-1. PubMed ID: 7270397
    [No Abstract]   [Full Text] [Related]  

  • 56. Haemoconcentration and deep venous thrombosis.
    Janvrin SB; Davies G; Greenhalgh RM
    Lancet; 1981 Jul; 2(8236):50. PubMed ID: 6113426
    [No Abstract]   [Full Text] [Related]  

  • 57. Evidence and education.
    Antman EM
    Circulation; 2011 Feb; 123(6):681-5. PubMed ID: 21321184
    [No Abstract]   [Full Text] [Related]  

  • 58. Diet as prophylaxis and treatment for venous thromboembolism?
    Cundiff DK; Agutter PS; Malone PC; Pezzullo JC
    Theor Biol Med Model; 2010 Aug; 7():31. PubMed ID: 20701748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A systematic review of Cochrane anticoagulation reviews.
    Cundiff DK
    Medscape J Med; 2009; 11(1):5. PubMed ID: 19295926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism.
    Cundiff DK
    Medscape J Med; 2008; 10(11):258. PubMed ID: 19099008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.